Martingale Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $502K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $425K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $271K | Buy |
|
|||||
|
2023
Q2 | $354K | Sell |
|
|||||
|
2023
Q1 | $545K | Buy |
|
|||||
|
2022
Q4 | $485K | Buy |
|
|||||
|
2022
Q3 | $588K | Buy |
|
|||||
|
2022
Q2 | $671K | Hold |
|
|||||
|
2022
Q1 | $887K | Sell |
|
|||||
|
2021
Q4 | $961K | Buy |
|
|||||
|
2021
Q3 | $1.02M | Buy |
|
|||||
|
2021
Q2 | $776K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $374K | Sell |
|
|||||
|
2018
Q1 | $1.09M | Hold |
|
|||||
|
2017
Q4 | $958K | Buy |
|
|||||
|
2017
Q3 | $745K | Buy |
|
|||||
|
2017
Q2 | $452K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $374K | Sell |
|
|||||
|
2015
Q4 | $412K | Sell |
|
|||||
|
2015
Q3 | $422K | Sell |
|
|||||
|
2015
Q2 | $795K | Sell |
|
|||||
|
2015
Q1 | $869K | Sell |
|
|||||
|
2014
Q4 | $859K | Sell |
|
|||||
|
2014
Q3 | $753K | Hold |
|
|||||
|
2014
Q2 | $794K | Sell |
|
|||||
|
2014
Q1 | $906K | Sell |
|
|||||
|
2013
Q4 | $847K | Sell |
|
|||||
|
2013
Q3 | $1.19M | Buy |
|
|||||
|
2013
Q2 | $901K | Buy |
|